Staging TDP-43 pathology in Alzheimer's disease

Acta Neuropathologica

Volumn 127, Issue 3, 2014, Pages 441-450

  Josephs, Keith A ^a   Murray, Melissa E ^b   Whitwell, Jennifer L ^a   Parisi, Joseph E ^a   Petrucelli, Leonard ^b   Jack, Clifford R ^a   Petersen, Ronald C ^a   Dickson, Dennis W ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Alzheimer disease; Amygdala; MRI; Staging; TDP 43; TDP 43 type

Indexed keywords

TAR DNA BINDING PROTEIN;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN SIZE; COGNITION; DENTATE GYRUS; DISEASE CLASSIFICATION; DISEASE DURATION; ENTORHINAL CORTEX; FEMALE; FRONTAL CORTEX; FUSIFORM GYRUS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PRIORITY JOURNAL; SUBICULUM; TDP 43 PROTEINOPATHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COGNITION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84896713213     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1211-9     Document Type: Article

References (42)

1. Amador-Ortiz C, Lin WL, Ahmed Z, et al. (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435-445
2. Arai T, Hasegawa M, Akiyama H, et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602-611
3. Arai T, Mackenzie IR, Hasegawa M, et al. (2009) Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117:125-136
4. Bigio EH, Mishra M, Hatanpaa KJ, et al. (2010) TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol 120:43-54. doi: 10.1007/s00401-010-0681-2
5. Bigio EH, Wu JY, Deng HX, et al. (2013) Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol 125:463-465. doi: 10.1007/s00401-013-1089-6
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
7. Brettschneider J, Del Tredici K, Toledo JB, et al. (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20-38. doi: 10.1002/ana.23937
8. Crook R, Hardy J, Duff K (1994) Single-day apolipoprotein E genotyping. J Neurosci Methods 53:125-127
9. Davidson YS, Raby S, Foulds PG, et al. (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703-713. doi: 10.1007/s00401-011-0879-y
10. Dickson DW, Davies P, Bevona C, et al. (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (>or =80 years of age) humans. Acta Neuropathol 88:212-221
11. Dickson DW, Baker M, Rademakers R (2010) Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170-174. doi: 10.1159/000289231
12. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
13. Geser F, Robinson JL, Malunda JA, et al. (2010) Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 67:1238-1250. doi: 10.1001/archneurol.2010. 254
14. Higashi S, Iseki E, Yamamoto R, et al. (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184:284-294. doi: 10.1016/j.brainres.2007.09.048
15. Hu WT, Josephs KA, Knopman DS, et al. (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116:215-220
16. Jack CR Jr, Lowe VJ, Senjem ML, et al. (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain J Neurol 131:665-680. doi: 10.1093/brain/awm336
17. Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579-1584. doi: 10.1001/archneur.61.10.1579
18. Josephs KA, Whitwell JL, Knopman DS, et al. (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850-1857
19. Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118:349-358
20. Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K (2009) Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathol Off J Jpn Soc Neuropathol 29:566-573. doi: 10.1111/j.1440-1789.2009.01017.x
21. Kaplan E, Goodglass H, Weintraub S (1978) The Boston Naming Test. Veterans Administration Medical Center, City
22. King A, Sweeney F, Bodi I, Troakes C, Maekawa S, Al-Sarraj S (2010) Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathol Off J Jpn Soc Neuropathol 30:408-419. doi: 10.1111/j.1440-1789.2009.01085.x
23. King OD, Gitler AD, Shorter J (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 1462:61-80. doi: 10.1016/j.brainres.2012.01.016
24. Lin WL, Dickson DW (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 116:205-213. doi: 10.1007/s00401-008-0408-9
25. Mackenzie IR, Baborie A, Pickering-Brown S, et al. (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 112:539-549. doi: 10.1007/s00401-006-0138-9
26. Mackenzie IR, Neumann M, Baborie A, et al. (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111-113. doi: 10.1007/s00401-011-0845-8
27. Mattis S (1988) Dementia rating scale. Psychological Assessment Resources, City
28. Mirra SS, Heyman A, McKeel D, et al. (1991) The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
29. Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412-2414
30. Nelson PT, Schmitt FA, Lin Y, et al. (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain J Neurol 134:1506-1518. doi: 10.1093/brain/awr053
31. Neumann M, Sampathu DM, Kwong LK, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133
32. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR (2011) Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 25:364-368. doi: 10.1097/WAD.0b013e31820f8f50
33. Robinson JL, Geser F, Corrada MM, et al. (2011) Neocortical and hippocampal amyloid-beta and tau measures associate with dementia in the oldest-old. Brain J Neurol 134:3708-3715. doi: 10.1093/brain/awr308
34. Sampathu DM, Neumann M, Kwong LK, et al. (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169:1343-1352. doi: 10.2353/ajpath.2006.060438
35. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97
36. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273-289
37. Uryu K, Nakashima-Yasuda H, Forman MS, et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555-564
38. Whitwell JL, Jack CR Jr, Przybelski SA, et al. (2011) Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 32:1531-1541
39. Whitwell JL, Dickson DW, Murray ME, et al. (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol 11:868-877. doi: 10.1016/S1474-4422(12)70200-4
40. Working Group (1997) Consensus recommendation for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for Neuropathologic Assessment of Alzheimer's Disease. Neurobiol Aging 18(1):1-2
41. Yokota O, Davidson Y, Bigio EH, et al. (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55-66. doi: 10.1007/s00401-010-0702-1
42. Zhang YJ, Xu YF, Cook C, et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106:7607-7612. doi: 10.1073/pnas.09006881060900688106